| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.5 | 0.07 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.31 | 0.07 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |